**Question:** Thierch graft consists of

A. autologous bone marrow
B. allogeneic bone marrow
C. peripheral blood stem cells
D. hematopoietic stem cells

**Core Concept:** Thierch graft, also known as myeloablative chemotherapy followed by hematopoietic stem cell transplantation, is a procedure used in the treatment of various hematological malignancies and genetic disorders. It involves a combination of high-dose chemotherapy and radiation therapy to destroy the patient's bone marrow, followed by infusion of hematopoietic stem cells to regenerate the bone marrow and restore hematopoiesis.

**Why the Correct Answer is Right:**

The correct answer is Thierch graft using **D** hematopoietic stem cells. In this procedure, hematopoietic stem cells (HSCs) are collected from the patient (autologous) or a compatible donor (allogeneic), usually through apheresis, and then infused back into the patient after the bone marrow has been destroyed by intense conditioning therapy. HSCs are essential for hematopoiesis, the process of producing blood cells, and their restoration leads to the regeneration of functional blood cells in the bone marrow.

**Why Each Wrong Option is Incorrect:**

**A:** Autologous bone marrow is not the correct option for Thierch graft as the conditioning therapy destroys the patient's own bone marrow, making autologous bone marrow unsuitable for the transplantation process.

**B:** Allogeneic bone marrow is not the correct option for Thierch graft as it involves the use of HSCs from a compatible donor, typically a close family member, to ensure an immune-compatible transplant. Autologous bone marrow transplantation would involve the patient's own bone marrow cells.

**C:** Peripheral blood stem cells (PBSCs) are a type of hematopoietic stem cells, but they are not the correct option for Thierch graft as they are not thoroughly purified and characterized like HSCs obtained through apheresis. Thierch graft involves the use of highly purified and tested HSCs for transplantation.

**Clinical Pearl:** A crucial aspect of Thierch graft is the use of **D** hematopoietic stem cells (HSCs) for restoring hematopoiesis after conditioning therapy. This transplantation of HSCs ensures the regeneration of functional blood cells and the prevention of graft-versus-host disease (GVHD) which is a major concern with allogeneic transplantation.